Trial Outcomes & Findings for Reduction of Nocturnal Hypoglycemia and Hyperglycemia in the Home Using Predictive Algorithms (NCT NCT02438189)

NCT ID: NCT02438189

Last Updated: 2026-08-11

Results Overview

Mean percent of time participant spent with glucose values 70-180 mg/dl, measured by continuous glucose monitor of each night

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

33 participants

Primary outcome timeframe

Up to 42 nights

Results posted on

2026-08-11

Participant Flow

The study was conducted at Stanford University (Stanford, CA), the Barbara Davis Center (Denver, CO), and Children's Hospital, London Health Sciences Centre (London, ON). A total of 33 subjects were enrolled, with 30 entering the randomized trial and and completing the study.

A run-in phase preceded the randomized trial. During the initial part of the run-in phase, the sensor was initiated and used for 14-21 days to verify that the participant could successfully use the pump and sensor. Successful participants then used the PHHM system at home for 5 nights to verify the ability to use it successfully.

Participant milestones

Participant milestones
Measure
Randomized Nights - PHHM or PLGS
Each night, following initiation procedures, the system randomly activated either PHHM or PLGS according to a predefined schedule with the aim of completing 21 nights with PHHM and 21 nights with PLGS. Participants were blinded to the assignment.
Overall Study
STARTED
33
Overall Study
COMPLETED
30
Overall Study
NOT COMPLETED
3

Reasons for withdrawal

Reasons for withdrawal
Measure
Randomized Nights - PHHM or PLGS
Each night, following initiation procedures, the system randomly activated either PHHM or PLGS according to a predefined schedule with the aim of completing 21 nights with PHHM and 21 nights with PLGS. Participants were blinded to the assignment.
Overall Study
Withdrawal by Subject
3

Baseline Characteristics

Reduction of Nocturnal Hypoglycemia and Hyperglycemia in the Home Using Predictive Algorithms

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Randomized Nights - PHHM or PLGS
n=30 Participants
Each night, following initiation procedures, the system randomly activated either PHHM or PLGS according to a predefined schedule with the aim of completing 21 nights with PHHM and 21 nights with PLGS. Participants were blinded to the assignment.
Age, Continuous
31 years
n=54 Participants
Sex: Female, Male
Female
15 Participants
n=54 Participants
Sex: Female, Male
Male
15 Participants
n=54 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
2 Participants
n=54 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
27 Participants
n=54 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
1 Participants
n=54 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=54 Participants
Race (NIH/OMB)
Asian
0 Participants
n=54 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
1 Participants
n=54 Participants
Race (NIH/OMB)
Black or African American
0 Participants
n=54 Participants
Race (NIH/OMB)
White
28 Participants
n=54 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=54 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants
n=54 Participants
Region of Enrollment
Canada
10 participants
n=54 Participants
Region of Enrollment
United States
20 participants
n=54 Participants
Diabetes duration
17 years
n=54 Participants
Body-mass index
26.4 kg/m^2
n=54 Participants
Daily insulin dose
0.58 U/kg/day
n=54 Participants
Enrollment HbA1c
7.5 percentage of hemoglobin A1c
n=54 Participants

PRIMARY outcome

Timeframe: Up to 42 nights

Mean percent of time participant spent with glucose values 70-180 mg/dl, measured by continuous glucose monitor of each night

Outcome measures

Outcome measures
Measure
Predictive Low Glucose Suspend (PLGS)
n=30 Participants
A predictive hypoglycemia minimization algorithm ran and suspended the pump if the current sensor glucose was ≤70 mg/dL at any time or \<230 mg/dL and predicted to fall below 80 mg/dL in the next 50 minutes. Basal insulin was restored on the first sensor rise during insulin suspension, and suspension time could not exceed 120 minutes in a 150 minute window or a cumulative total of 180 minutes per night. Predictive Hypoglycemia Minimization Algorithm: A predictive hypoglycemia minimization designed to suspend the pump if the current sensor glucose is ≤70 mg/dL at any time or \<230 mg/dL and predicted to fall below 80 mg/dL in the next 50 minutes
Predictive Hyper/Hypo Minimizer (PHHM)
n=30 Participants
A predictive hyperglycemia minimization algorithm ran actively on the study laptop during the night and delivered automated correction boluses when the estimated glucose was predicted to exceed 140 mg/dL. In addition, a predictive hypoglycemia minimization algorithm ran and suspended the pump if the current sensor glucose was ≤70 mg/dL at any time or \<230 mg/dL and predicted to fall below 80 mg/dL in the next 50 minutes. Predictive Hyperglycemia Minimization Algorithm: A predictive hyperglycemia minimization algorithm designed to deliver automated correction boluses when the estimated glucose is predicted to exceed 140 mg/dL Predictive Hypoglycemia Minimization Algorithm: A predictive hypoglycemia minimization designed to suspend the pump if the current sensor glucose is ≤70 mg/dL at any time or \<230 mg/dL and predicted to fall below 80 mg/dL in the next 50 minutes
Percent Time Spent 70-180 mg/dL
71 percent
Standard Deviation 10
78 percent
Standard Deviation 10

SECONDARY outcome

Timeframe: Up to 42 nights

Mean CGM sensor glucose

Outcome measures

Outcome measures
Measure
Predictive Low Glucose Suspend (PLGS)
n=30 Participants
A predictive hypoglycemia minimization algorithm ran and suspended the pump if the current sensor glucose was ≤70 mg/dL at any time or \<230 mg/dL and predicted to fall below 80 mg/dL in the next 50 minutes. Basal insulin was restored on the first sensor rise during insulin suspension, and suspension time could not exceed 120 minutes in a 150 minute window or a cumulative total of 180 minutes per night. Predictive Hypoglycemia Minimization Algorithm: A predictive hypoglycemia minimization designed to suspend the pump if the current sensor glucose is ≤70 mg/dL at any time or \<230 mg/dL and predicted to fall below 80 mg/dL in the next 50 minutes
Predictive Hyper/Hypo Minimizer (PHHM)
n=30 Participants
A predictive hyperglycemia minimization algorithm ran actively on the study laptop during the night and delivered automated correction boluses when the estimated glucose was predicted to exceed 140 mg/dL. In addition, a predictive hypoglycemia minimization algorithm ran and suspended the pump if the current sensor glucose was ≤70 mg/dL at any time or \<230 mg/dL and predicted to fall below 80 mg/dL in the next 50 minutes. Predictive Hyperglycemia Minimization Algorithm: A predictive hyperglycemia minimization algorithm designed to deliver automated correction boluses when the estimated glucose is predicted to exceed 140 mg/dL Predictive Hypoglycemia Minimization Algorithm: A predictive hypoglycemia minimization designed to suspend the pump if the current sensor glucose is ≤70 mg/dL at any time or \<230 mg/dL and predicted to fall below 80 mg/dL in the next 50 minutes
Mean Sensor Glucose
152 mg/dL
Standard Deviation 16
143 mg/dL
Standard Deviation 15

SECONDARY outcome

Timeframe: Up to 42 nights

Median percent of time participant spent with glucose values \<50 mg/dl, measured by continuous glucose monitor of each night.

Outcome measures

Outcome measures
Measure
Predictive Low Glucose Suspend (PLGS)
n=30 Participants
A predictive hypoglycemia minimization algorithm ran and suspended the pump if the current sensor glucose was ≤70 mg/dL at any time or \<230 mg/dL and predicted to fall below 80 mg/dL in the next 50 minutes. Basal insulin was restored on the first sensor rise during insulin suspension, and suspension time could not exceed 120 minutes in a 150 minute window or a cumulative total of 180 minutes per night. Predictive Hypoglycemia Minimization Algorithm: A predictive hypoglycemia minimization designed to suspend the pump if the current sensor glucose is ≤70 mg/dL at any time or \<230 mg/dL and predicted to fall below 80 mg/dL in the next 50 minutes
Predictive Hyper/Hypo Minimizer (PHHM)
n=30 Participants
A predictive hyperglycemia minimization algorithm ran actively on the study laptop during the night and delivered automated correction boluses when the estimated glucose was predicted to exceed 140 mg/dL. In addition, a predictive hypoglycemia minimization algorithm ran and suspended the pump if the current sensor glucose was ≤70 mg/dL at any time or \<230 mg/dL and predicted to fall below 80 mg/dL in the next 50 minutes. Predictive Hyperglycemia Minimization Algorithm: A predictive hyperglycemia minimization algorithm designed to deliver automated correction boluses when the estimated glucose is predicted to exceed 140 mg/dL Predictive Hypoglycemia Minimization Algorithm: A predictive hypoglycemia minimization designed to suspend the pump if the current sensor glucose is ≤70 mg/dL at any time or \<230 mg/dL and predicted to fall below 80 mg/dL in the next 50 minutes
Percent Time Spent <50 mg/dL (2.8 mmol/L)
0.0 percent
Interval 0.0 to 0.2
0.1 percent
Interval 0.0 to 0.2

SECONDARY outcome

Timeframe: Up to 42 nights

Median percent of time participant spent with glucose values \<60 mg/dl, measured by continuous glucose monitor of each night

Outcome measures

Outcome measures
Measure
Predictive Low Glucose Suspend (PLGS)
n=30 Participants
A predictive hypoglycemia minimization algorithm ran and suspended the pump if the current sensor glucose was ≤70 mg/dL at any time or \<230 mg/dL and predicted to fall below 80 mg/dL in the next 50 minutes. Basal insulin was restored on the first sensor rise during insulin suspension, and suspension time could not exceed 120 minutes in a 150 minute window or a cumulative total of 180 minutes per night. Predictive Hypoglycemia Minimization Algorithm: A predictive hypoglycemia minimization designed to suspend the pump if the current sensor glucose is ≤70 mg/dL at any time or \<230 mg/dL and predicted to fall below 80 mg/dL in the next 50 minutes
Predictive Hyper/Hypo Minimizer (PHHM)
n=30 Participants
A predictive hyperglycemia minimization algorithm ran actively on the study laptop during the night and delivered automated correction boluses when the estimated glucose was predicted to exceed 140 mg/dL. In addition, a predictive hypoglycemia minimization algorithm ran and suspended the pump if the current sensor glucose was ≤70 mg/dL at any time or \<230 mg/dL and predicted to fall below 80 mg/dL in the next 50 minutes. Predictive Hyperglycemia Minimization Algorithm: A predictive hyperglycemia minimization algorithm designed to deliver automated correction boluses when the estimated glucose is predicted to exceed 140 mg/dL Predictive Hypoglycemia Minimization Algorithm: A predictive hypoglycemia minimization designed to suspend the pump if the current sensor glucose is ≤70 mg/dL at any time or \<230 mg/dL and predicted to fall below 80 mg/dL in the next 50 minutes
Percent of Time Spent <60 mg/dL (3.3 mmol/L)
0.3 percent
Interval 0.0 to 1.0
0.4 percent
Interval 0.1 to 0.8

SECONDARY outcome

Timeframe: Up to 42 nights

Median percent of time participant spent with glucose values \<70 mg/dl, measured by continuous glucose monitor of each night

Outcome measures

Outcome measures
Measure
Predictive Low Glucose Suspend (PLGS)
n=30 Participants
A predictive hypoglycemia minimization algorithm ran and suspended the pump if the current sensor glucose was ≤70 mg/dL at any time or \<230 mg/dL and predicted to fall below 80 mg/dL in the next 50 minutes. Basal insulin was restored on the first sensor rise during insulin suspension, and suspension time could not exceed 120 minutes in a 150 minute window or a cumulative total of 180 minutes per night. Predictive Hypoglycemia Minimization Algorithm: A predictive hypoglycemia minimization designed to suspend the pump if the current sensor glucose is ≤70 mg/dL at any time or \<230 mg/dL and predicted to fall below 80 mg/dL in the next 50 minutes
Predictive Hyper/Hypo Minimizer (PHHM)
n=30 Participants
A predictive hyperglycemia minimization algorithm ran actively on the study laptop during the night and delivered automated correction boluses when the estimated glucose was predicted to exceed 140 mg/dL. In addition, a predictive hypoglycemia minimization algorithm ran and suspended the pump if the current sensor glucose was ≤70 mg/dL at any time or \<230 mg/dL and predicted to fall below 80 mg/dL in the next 50 minutes. Predictive Hyperglycemia Minimization Algorithm: A predictive hyperglycemia minimization algorithm designed to deliver automated correction boluses when the estimated glucose is predicted to exceed 140 mg/dL Predictive Hypoglycemia Minimization Algorithm: A predictive hypoglycemia minimization designed to suspend the pump if the current sensor glucose is ≤70 mg/dL at any time or \<230 mg/dL and predicted to fall below 80 mg/dL in the next 50 minutes
Percent Time Spent <70 mg/dL (3.9 mmol/L)
1.0 percent
Interval 0.6 to 2.5
1.1 percent
Interval 0.7 to 2.3

SECONDARY outcome

Timeframe: Up to 42 nights

Median percent of time participant spent with glucose values \>180 mg/dl, measured by continuous glucose monitor of each night

Outcome measures

Outcome measures
Measure
Predictive Low Glucose Suspend (PLGS)
n=30 Participants
A predictive hypoglycemia minimization algorithm ran and suspended the pump if the current sensor glucose was ≤70 mg/dL at any time or \<230 mg/dL and predicted to fall below 80 mg/dL in the next 50 minutes. Basal insulin was restored on the first sensor rise during insulin suspension, and suspension time could not exceed 120 minutes in a 150 minute window or a cumulative total of 180 minutes per night. Predictive Hypoglycemia Minimization Algorithm: A predictive hypoglycemia minimization designed to suspend the pump if the current sensor glucose is ≤70 mg/dL at any time or \<230 mg/dL and predicted to fall below 80 mg/dL in the next 50 minutes
Predictive Hyper/Hypo Minimizer (PHHM)
n=30 Participants
A predictive hyperglycemia minimization algorithm ran actively on the study laptop during the night and delivered automated correction boluses when the estimated glucose was predicted to exceed 140 mg/dL. In addition, a predictive hypoglycemia minimization algorithm ran and suspended the pump if the current sensor glucose was ≤70 mg/dL at any time or \<230 mg/dL and predicted to fall below 80 mg/dL in the next 50 minutes. Predictive Hyperglycemia Minimization Algorithm: A predictive hyperglycemia minimization algorithm designed to deliver automated correction boluses when the estimated glucose is predicted to exceed 140 mg/dL Predictive Hypoglycemia Minimization Algorithm: A predictive hypoglycemia minimization designed to suspend the pump if the current sensor glucose is ≤70 mg/dL at any time or \<230 mg/dL and predicted to fall below 80 mg/dL in the next 50 minutes
Percent Time Spent >180 mg/dL (10.0 mmol/L)
26 percent of time
Interval 21.0 to 35.0
20 percent of time
Interval 14.0 to 26.0

SECONDARY outcome

Timeframe: 42 nights

Median percent of time participant spent with glucose values \>250 mg/dl, measured by continuous glucose monitor of each night

Outcome measures

Outcome measures
Measure
Predictive Low Glucose Suspend (PLGS)
n=30 Participants
A predictive hypoglycemia minimization algorithm ran and suspended the pump if the current sensor glucose was ≤70 mg/dL at any time or \<230 mg/dL and predicted to fall below 80 mg/dL in the next 50 minutes. Basal insulin was restored on the first sensor rise during insulin suspension, and suspension time could not exceed 120 minutes in a 150 minute window or a cumulative total of 180 minutes per night. Predictive Hypoglycemia Minimization Algorithm: A predictive hypoglycemia minimization designed to suspend the pump if the current sensor glucose is ≤70 mg/dL at any time or \<230 mg/dL and predicted to fall below 80 mg/dL in the next 50 minutes
Predictive Hyper/Hypo Minimizer (PHHM)
n=30 Participants
A predictive hyperglycemia minimization algorithm ran actively on the study laptop during the night and delivered automated correction boluses when the estimated glucose was predicted to exceed 140 mg/dL. In addition, a predictive hypoglycemia minimization algorithm ran and suspended the pump if the current sensor glucose was ≤70 mg/dL at any time or \<230 mg/dL and predicted to fall below 80 mg/dL in the next 50 minutes. Predictive Hyperglycemia Minimization Algorithm: A predictive hyperglycemia minimization algorithm designed to deliver automated correction boluses when the estimated glucose is predicted to exceed 140 mg/dL Predictive Hypoglycemia Minimization Algorithm: A predictive hypoglycemia minimization designed to suspend the pump if the current sensor glucose is ≤70 mg/dL at any time or \<230 mg/dL and predicted to fall below 80 mg/dL in the next 50 minutes
Percent Time Spent >250 mg/dL (13.9 mmol/L)
5 percent
Interval 2.0 to 9.0
2 percent
Interval 1.0 to 3.0

SECONDARY outcome

Timeframe: Up to 42 nights

Median percent of time participant spent with glucose values \>300 mg/dl (16.7 mmol/L), measured by continuous glucose monitor of each night

Outcome measures

Outcome measures
Measure
Predictive Low Glucose Suspend (PLGS)
n=30 Participants
A predictive hypoglycemia minimization algorithm ran and suspended the pump if the current sensor glucose was ≤70 mg/dL at any time or \<230 mg/dL and predicted to fall below 80 mg/dL in the next 50 minutes. Basal insulin was restored on the first sensor rise during insulin suspension, and suspension time could not exceed 120 minutes in a 150 minute window or a cumulative total of 180 minutes per night. Predictive Hypoglycemia Minimization Algorithm: A predictive hypoglycemia minimization designed to suspend the pump if the current sensor glucose is ≤70 mg/dL at any time or \<230 mg/dL and predicted to fall below 80 mg/dL in the next 50 minutes
Predictive Hyper/Hypo Minimizer (PHHM)
n=30 Participants
A predictive hyperglycemia minimization algorithm ran actively on the study laptop during the night and delivered automated correction boluses when the estimated glucose was predicted to exceed 140 mg/dL. In addition, a predictive hypoglycemia minimization algorithm ran and suspended the pump if the current sensor glucose was ≤70 mg/dL at any time or \<230 mg/dL and predicted to fall below 80 mg/dL in the next 50 minutes. Predictive Hyperglycemia Minimization Algorithm: A predictive hyperglycemia minimization algorithm designed to deliver automated correction boluses when the estimated glucose is predicted to exceed 140 mg/dL Predictive Hypoglycemia Minimization Algorithm: A predictive hypoglycemia minimization designed to suspend the pump if the current sensor glucose is ≤70 mg/dL at any time or \<230 mg/dL and predicted to fall below 80 mg/dL in the next 50 minutes
Percent Time Spent >300 mg/dL (16.7 mmol/L)
0.2 Percent of time
Interval 0.0 to 1.3
0.1 Percent of time
Interval 0.0 to 0.2

SECONDARY outcome

Timeframe: Up to 42 nights

Percent of time participant spent \>30 minutes and \>60 minutes consecutively with glucose values \<50 mg/dl (2.8 mmol/L) of all nights

Outcome measures

Outcome measures
Measure
Predictive Low Glucose Suspend (PLGS)
n=30 Participants
A predictive hypoglycemia minimization algorithm ran and suspended the pump if the current sensor glucose was ≤70 mg/dL at any time or \<230 mg/dL and predicted to fall below 80 mg/dL in the next 50 minutes. Basal insulin was restored on the first sensor rise during insulin suspension, and suspension time could not exceed 120 minutes in a 150 minute window or a cumulative total of 180 minutes per night. Predictive Hypoglycemia Minimization Algorithm: A predictive hypoglycemia minimization designed to suspend the pump if the current sensor glucose is ≤70 mg/dL at any time or \<230 mg/dL and predicted to fall below 80 mg/dL in the next 50 minutes
Predictive Hyper/Hypo Minimizer (PHHM)
n=30 Participants
A predictive hyperglycemia minimization algorithm ran actively on the study laptop during the night and delivered automated correction boluses when the estimated glucose was predicted to exceed 140 mg/dL. In addition, a predictive hypoglycemia minimization algorithm ran and suspended the pump if the current sensor glucose was ≤70 mg/dL at any time or \<230 mg/dL and predicted to fall below 80 mg/dL in the next 50 minutes. Predictive Hyperglycemia Minimization Algorithm: A predictive hyperglycemia minimization algorithm designed to deliver automated correction boluses when the estimated glucose is predicted to exceed 140 mg/dL Predictive Hypoglycemia Minimization Algorithm: A predictive hypoglycemia minimization designed to suspend the pump if the current sensor glucose is ≤70 mg/dL at any time or \<230 mg/dL and predicted to fall below 80 mg/dL in the next 50 minutes
Percent Time Spent >30 Min and >60 Min Consecutive <50 mg/dL (2.8 mmol/L)
2 Percent
3 Percent

SECONDARY outcome

Timeframe: Up to 42 nights

Percent of time participant spent \>30 minutes and \>60 minutes consecutively with glucose values \<60 mg/dl (3.3 mmol/mol) of all nights

Outcome measures

Outcome measures
Measure
Predictive Low Glucose Suspend (PLGS)
n=30 Participants
A predictive hypoglycemia minimization algorithm ran and suspended the pump if the current sensor glucose was ≤70 mg/dL at any time or \<230 mg/dL and predicted to fall below 80 mg/dL in the next 50 minutes. Basal insulin was restored on the first sensor rise during insulin suspension, and suspension time could not exceed 120 minutes in a 150 minute window or a cumulative total of 180 minutes per night. Predictive Hypoglycemia Minimization Algorithm: A predictive hypoglycemia minimization designed to suspend the pump if the current sensor glucose is ≤70 mg/dL at any time or \<230 mg/dL and predicted to fall below 80 mg/dL in the next 50 minutes
Predictive Hyper/Hypo Minimizer (PHHM)
n=30 Participants
A predictive hyperglycemia minimization algorithm ran actively on the study laptop during the night and delivered automated correction boluses when the estimated glucose was predicted to exceed 140 mg/dL. In addition, a predictive hypoglycemia minimization algorithm ran and suspended the pump if the current sensor glucose was ≤70 mg/dL at any time or \<230 mg/dL and predicted to fall below 80 mg/dL in the next 50 minutes. Predictive Hyperglycemia Minimization Algorithm: A predictive hyperglycemia minimization algorithm designed to deliver automated correction boluses when the estimated glucose is predicted to exceed 140 mg/dL Predictive Hypoglycemia Minimization Algorithm: A predictive hypoglycemia minimization designed to suspend the pump if the current sensor glucose is ≤70 mg/dL at any time or \<230 mg/dL and predicted to fall below 80 mg/dL in the next 50 minutes
Percent Time Spent >30 Min and >60 Min Consecutively <60 mg/dL (3.3 mmol/L)
8 percent
8 percent

SECONDARY outcome

Timeframe: Up to 42 nights

Percent of time participant spent with \>30 min and \>60 min consecutively \<70 mg/dL (3.9 mmol/L) of all nights

Outcome measures

Outcome measures
Measure
Predictive Low Glucose Suspend (PLGS)
n=30 Participants
A predictive hypoglycemia minimization algorithm ran and suspended the pump if the current sensor glucose was ≤70 mg/dL at any time or \<230 mg/dL and predicted to fall below 80 mg/dL in the next 50 minutes. Basal insulin was restored on the first sensor rise during insulin suspension, and suspension time could not exceed 120 minutes in a 150 minute window or a cumulative total of 180 minutes per night. Predictive Hypoglycemia Minimization Algorithm: A predictive hypoglycemia minimization designed to suspend the pump if the current sensor glucose is ≤70 mg/dL at any time or \<230 mg/dL and predicted to fall below 80 mg/dL in the next 50 minutes
Predictive Hyper/Hypo Minimizer (PHHM)
n=30 Participants
A predictive hyperglycemia minimization algorithm ran actively on the study laptop during the night and delivered automated correction boluses when the estimated glucose was predicted to exceed 140 mg/dL. In addition, a predictive hypoglycemia minimization algorithm ran and suspended the pump if the current sensor glucose was ≤70 mg/dL at any time or \<230 mg/dL and predicted to fall below 80 mg/dL in the next 50 minutes. Predictive Hyperglycemia Minimization Algorithm: A predictive hyperglycemia minimization algorithm designed to deliver automated correction boluses when the estimated glucose is predicted to exceed 140 mg/dL Predictive Hypoglycemia Minimization Algorithm: A predictive hypoglycemia minimization designed to suspend the pump if the current sensor glucose is ≤70 mg/dL at any time or \<230 mg/dL and predicted to fall below 80 mg/dL in the next 50 minutes
Percent Time Spent With >30 Min and >60 Min Consecutively <70 mg/dL (3.9 mmol/L)
20 Percent
19 Percent

SECONDARY outcome

Timeframe: Up to 42 nights

Outcome measures

Outcome measures
Measure
Predictive Low Glucose Suspend (PLGS)
n=30 Participants
A predictive hypoglycemia minimization algorithm ran and suspended the pump if the current sensor glucose was ≤70 mg/dL at any time or \<230 mg/dL and predicted to fall below 80 mg/dL in the next 50 minutes. Basal insulin was restored on the first sensor rise during insulin suspension, and suspension time could not exceed 120 minutes in a 150 minute window or a cumulative total of 180 minutes per night. Predictive Hypoglycemia Minimization Algorithm: A predictive hypoglycemia minimization designed to suspend the pump if the current sensor glucose is ≤70 mg/dL at any time or \<230 mg/dL and predicted to fall below 80 mg/dL in the next 50 minutes
Predictive Hyper/Hypo Minimizer (PHHM)
n=30 Participants
A predictive hyperglycemia minimization algorithm ran actively on the study laptop during the night and delivered automated correction boluses when the estimated glucose was predicted to exceed 140 mg/dL. In addition, a predictive hypoglycemia minimization algorithm ran and suspended the pump if the current sensor glucose was ≤70 mg/dL at any time or \<230 mg/dL and predicted to fall below 80 mg/dL in the next 50 minutes. Predictive Hyperglycemia Minimization Algorithm: A predictive hyperglycemia minimization algorithm designed to deliver automated correction boluses when the estimated glucose is predicted to exceed 140 mg/dL Predictive Hypoglycemia Minimization Algorithm: A predictive hypoglycemia minimization designed to suspend the pump if the current sensor glucose is ≤70 mg/dL at any time or \<230 mg/dL and predicted to fall below 80 mg/dL in the next 50 minutes
Glucose Coefficient of Variation (CV)
34 Percent
Interval 30.0 to 37.0
31 Percent
Interval 27.0 to 34.0

SECONDARY outcome

Timeframe: Up to 42 nights

Outcome measures

Outcome measures
Measure
Predictive Low Glucose Suspend (PLGS)
n=30 Participants
A predictive hypoglycemia minimization algorithm ran and suspended the pump if the current sensor glucose was ≤70 mg/dL at any time or \<230 mg/dL and predicted to fall below 80 mg/dL in the next 50 minutes. Basal insulin was restored on the first sensor rise during insulin suspension, and suspension time could not exceed 120 minutes in a 150 minute window or a cumulative total of 180 minutes per night. Predictive Hypoglycemia Minimization Algorithm: A predictive hypoglycemia minimization designed to suspend the pump if the current sensor glucose is ≤70 mg/dL at any time or \<230 mg/dL and predicted to fall below 80 mg/dL in the next 50 minutes
Predictive Hyper/Hypo Minimizer (PHHM)
n=30 Participants
A predictive hyperglycemia minimization algorithm ran actively on the study laptop during the night and delivered automated correction boluses when the estimated glucose was predicted to exceed 140 mg/dL. In addition, a predictive hypoglycemia minimization algorithm ran and suspended the pump if the current sensor glucose was ≤70 mg/dL at any time or \<230 mg/dL and predicted to fall below 80 mg/dL in the next 50 minutes. Predictive Hyperglycemia Minimization Algorithm: A predictive hyperglycemia minimization algorithm designed to deliver automated correction boluses when the estimated glucose is predicted to exceed 140 mg/dL Predictive Hypoglycemia Minimization Algorithm: A predictive hypoglycemia minimization designed to suspend the pump if the current sensor glucose is ≤70 mg/dL at any time or \<230 mg/dL and predicted to fall below 80 mg/dL in the next 50 minutes
Amount of Total Insulin Boluses
7.5 insulin units
Interval 5.2 to 10.8
8.4 insulin units
Interval 6.0 to 12.0

SECONDARY outcome

Timeframe: Up to 42 nights

Outcome measures

Outcome measures
Measure
Predictive Low Glucose Suspend (PLGS)
n=30 Participants
A predictive hypoglycemia minimization algorithm ran and suspended the pump if the current sensor glucose was ≤70 mg/dL at any time or \<230 mg/dL and predicted to fall below 80 mg/dL in the next 50 minutes. Basal insulin was restored on the first sensor rise during insulin suspension, and suspension time could not exceed 120 minutes in a 150 minute window or a cumulative total of 180 minutes per night. Predictive Hypoglycemia Minimization Algorithm: A predictive hypoglycemia minimization designed to suspend the pump if the current sensor glucose is ≤70 mg/dL at any time or \<230 mg/dL and predicted to fall below 80 mg/dL in the next 50 minutes
Predictive Hyper/Hypo Minimizer (PHHM)
n=30 Participants
A predictive hyperglycemia minimization algorithm ran actively on the study laptop during the night and delivered automated correction boluses when the estimated glucose was predicted to exceed 140 mg/dL. In addition, a predictive hypoglycemia minimization algorithm ran and suspended the pump if the current sensor glucose was ≤70 mg/dL at any time or \<230 mg/dL and predicted to fall below 80 mg/dL in the next 50 minutes. Predictive Hyperglycemia Minimization Algorithm: A predictive hyperglycemia minimization algorithm designed to deliver automated correction boluses when the estimated glucose is predicted to exceed 140 mg/dL Predictive Hypoglycemia Minimization Algorithm: A predictive hypoglycemia minimization designed to suspend the pump if the current sensor glucose is ≤70 mg/dL at any time or \<230 mg/dL and predicted to fall below 80 mg/dL in the next 50 minutes
Mean Home Glucose Meter Morning Glucose
163 mg/dL
Standard Deviation 23
142 mg/dL
Standard Deviation 18

SECONDARY outcome

Timeframe: Up to 42 nights

Percent of mornings participant spent with glucose \>250 mg/dL (13.9 mmol/L), measured by home glucose monitor of all mornings

Outcome measures

Outcome measures
Measure
Predictive Low Glucose Suspend (PLGS)
n=30 Participants
A predictive hypoglycemia minimization algorithm ran and suspended the pump if the current sensor glucose was ≤70 mg/dL at any time or \<230 mg/dL and predicted to fall below 80 mg/dL in the next 50 minutes. Basal insulin was restored on the first sensor rise during insulin suspension, and suspension time could not exceed 120 minutes in a 150 minute window or a cumulative total of 180 minutes per night. Predictive Hypoglycemia Minimization Algorithm: A predictive hypoglycemia minimization designed to suspend the pump if the current sensor glucose is ≤70 mg/dL at any time or \<230 mg/dL and predicted to fall below 80 mg/dL in the next 50 minutes
Predictive Hyper/Hypo Minimizer (PHHM)
n=30 Participants
A predictive hyperglycemia minimization algorithm ran actively on the study laptop during the night and delivered automated correction boluses when the estimated glucose was predicted to exceed 140 mg/dL. In addition, a predictive hypoglycemia minimization algorithm ran and suspended the pump if the current sensor glucose was ≤70 mg/dL at any time or \<230 mg/dL and predicted to fall below 80 mg/dL in the next 50 minutes. Predictive Hyperglycemia Minimization Algorithm: A predictive hyperglycemia minimization algorithm designed to deliver automated correction boluses when the estimated glucose is predicted to exceed 140 mg/dL Predictive Hypoglycemia Minimization Algorithm: A predictive hypoglycemia minimization designed to suspend the pump if the current sensor glucose is ≤70 mg/dL at any time or \<230 mg/dL and predicted to fall below 80 mg/dL in the next 50 minutes
Percent of Mornings With Glucose >250 mg/dL (13.9 mmol/L)
8 percent
2 percent

SECONDARY outcome

Timeframe: Up to 42 nights

Percent of time participant spent with glucose values 70 to 180 mg/dl (2.8 mmol/L), measured by continuous glucose monitor, during each night

Outcome measures

Outcome measures
Measure
Predictive Low Glucose Suspend (PLGS)
n=30 Participants
A predictive hypoglycemia minimization algorithm ran and suspended the pump if the current sensor glucose was ≤70 mg/dL at any time or \<230 mg/dL and predicted to fall below 80 mg/dL in the next 50 minutes. Basal insulin was restored on the first sensor rise during insulin suspension, and suspension time could not exceed 120 minutes in a 150 minute window or a cumulative total of 180 minutes per night. Predictive Hypoglycemia Minimization Algorithm: A predictive hypoglycemia minimization designed to suspend the pump if the current sensor glucose is ≤70 mg/dL at any time or \<230 mg/dL and predicted to fall below 80 mg/dL in the next 50 minutes
Predictive Hyper/Hypo Minimizer (PHHM)
n=30 Participants
A predictive hyperglycemia minimization algorithm ran actively on the study laptop during the night and delivered automated correction boluses when the estimated glucose was predicted to exceed 140 mg/dL. In addition, a predictive hypoglycemia minimization algorithm ran and suspended the pump if the current sensor glucose was ≤70 mg/dL at any time or \<230 mg/dL and predicted to fall below 80 mg/dL in the next 50 minutes. Predictive Hyperglycemia Minimization Algorithm: A predictive hyperglycemia minimization algorithm designed to deliver automated correction boluses when the estimated glucose is predicted to exceed 140 mg/dL Predictive Hypoglycemia Minimization Algorithm: A predictive hypoglycemia minimization designed to suspend the pump if the current sensor glucose is ≤70 mg/dL at any time or \<230 mg/dL and predicted to fall below 80 mg/dL in the next 50 minutes
Percent Time Spent 70 to 180 mg/dL (3.9 to 10.0 mmol/L) Overnight
71 percent
Standard Deviation 10
78 percent
Standard Deviation 10

Adverse Events

Predictive Low Glucose Suspend (PLGS)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Predictive Hyper/Hypo Minimizer (PHHM)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

John Lum

Jaeb Center for Health Research

Phone: 8139758690

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place